HYPD
Price
$8.29
Change
-$1.33 (-13.84%)
Updated
Sep 25, 02:44 PM (EDT)
Capitalization
54.73M
INM
Price
$2.18
Change
-$0.00 (-0.00%)
Updated
Sep 25, 02:28 PM (EDT)
Capitalization
4.36M
Interact to see
Advertisement

HYPD vs INM

Header iconHYPD vs INM Comparison
Open Charts HYPD vs INMBanner chart's image
Hyperion DeFi
Price$8.29
Change-$1.33 (-13.84%)
Volume$200
Capitalization54.73M
InMed Pharmaceuticals
Price$2.18
Change-$0.00 (-0.00%)
Volume$584
Capitalization4.36M
HYPD vs INM Comparison Chart in %
Loading...
HYPD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HYPD vs. INM commentary
Sep 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HYPD is a Hold and INM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 25, 2025
Stock price -- (HYPD: $9.61 vs. INM: $2.18)
Brand notoriety: HYPD and INM are both not notable
HYPD represents the Biotechnology, while INM is part of the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: HYPD: 86% vs. INM: 44%
Market capitalization -- HYPD: $54.73M vs. INM: $4.36M
HYPD [@Biotechnology] is valued at $54.73M. INM’s [@Pharmaceuticals: Generic] market capitalization is $4.36M. The market cap for tickers in the [@Biotechnology] industry ranges from $96.56B to $0. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HYPD’s FA Score shows that 0 FA rating(s) are green whileINM’s FA Score has 0 green FA rating(s).

  • HYPD’s FA Score: 0 green, 5 red.
  • INM’s FA Score: 0 green, 5 red.
According to our system of comparison, HYPD is a better buy in the long-term than INM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HYPD’s TA Score shows that 5 TA indicator(s) are bullish while INM’s TA Score has 4 bullish TA indicator(s).

  • HYPD’s TA Score: 5 bullish, 5 bearish.
  • INM’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, INM is a better buy in the short-term than HYPD.

Price Growth

HYPD (@Biotechnology) experienced а -21.62% price change this week, while INM (@Pharmaceuticals: Generic) price change was -7.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.31%. For the same industry, the average monthly price growth was +9.06%, and the average quarterly price growth was +49.27%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +4.44%. For the same industry, the average monthly price growth was +25.74%, and the average quarterly price growth was +69.88%.

Industries' Descriptions

@Biotechnology (+1.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Pharmaceuticals: Generic (+4.44% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HYPD($54.7M) has a higher market cap than INM($4.37M). HYPD YTD gains are higher at: 6482.191 vs. INM (-52.505). INM has higher annual earnings (EBITDA): -7.86M vs. HYPD (-37.19M). HYPD has more cash in the bank: 7.53M vs. INM (4.68M). INM has less debt than HYPD: INM (849K) vs HYPD (8.47M). INM has higher revenues than HYPD: INM (4.92M) vs HYPD (44.4K).
HYPDINMHYPD / INM
Capitalization54.7M4.37M1,253%
EBITDA-37.19M-7.86M473%
Gain YTD6482.191-52.505-12,346%
P/E RatioN/A0.01-
Revenue44.4K4.92M1%
Total Cash7.53M4.68M161%
Total Debt8.47M849K997%
FUNDAMENTALS RATINGS
HYPD vs INM: Fundamental Ratings
HYPD
INM
OUTLOOK RATING
1..100
139
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
42
Fair valued
PROFIT vs RISK RATING
1..100
62100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
3491
P/E GROWTH RATING
1..100
10081
SEASONALITY SCORE
1..100
5090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INM's Valuation (42) in the null industry is in the same range as HYPD (63) in the Pharmaceuticals Major industry. This means that INM’s stock grew similarly to HYPD’s over the last 12 months.

HYPD's Profit vs Risk Rating (62) in the Pharmaceuticals Major industry is somewhat better than the same rating for INM (100) in the null industry. This means that HYPD’s stock grew somewhat faster than INM’s over the last 12 months.

INM's SMR Rating (99) in the null industry is in the same range as HYPD (100) in the Pharmaceuticals Major industry. This means that INM’s stock grew similarly to HYPD’s over the last 12 months.

HYPD's Price Growth Rating (34) in the Pharmaceuticals Major industry is somewhat better than the same rating for INM (91) in the null industry. This means that HYPD’s stock grew somewhat faster than INM’s over the last 12 months.

INM's P/E Growth Rating (81) in the null industry is in the same range as HYPD (100) in the Pharmaceuticals Major industry. This means that INM’s stock grew similarly to HYPD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HYPDINM
RSI
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 14 days ago
81%
Bullish Trend 9 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
HYPD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LICN4.920.20
+4.24%
Lichen International Limited
STC74.180.11
+0.15%
Stewart Information Services Corp
YHNA10.47N/A
N/A
YHN Acquisition I Ltd
CRS233.39-5.60
-2.34%
Carpenter Technology Corp
GMRE33.57-2.50
-6.93%
Global Medical REIT

HYPD and

Correlation & Price change

A.I.dvisor indicates that over the last year, HYPD has been loosely correlated with QNTM. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if HYPD jumps, then QNTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HYPD
1D Price
Change %
HYPD100%
-4.90%
QNTM - HYPD
34%
Loosely correlated
-6.70%
INKT - HYPD
34%
Loosely correlated
-3.89%
CTXR - HYPD
33%
Poorly correlated
+3.48%
VACBF - HYPD
32%
Poorly correlated
N/A
ACXP - HYPD
31%
Poorly correlated
+1.47%
More

INM and

Correlation & Price change

A.I.dvisor indicates that over the last year, INM has been loosely correlated with TTNP. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if INM jumps, then TTNP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INM
1D Price
Change %
INM100%
+1.87%
TTNP - INM
45%
Loosely correlated
+1.85%
HYPD - INM
39%
Loosely correlated
-4.90%
OMER - INM
36%
Loosely correlated
-1.87%
VTYX - INM
31%
Poorly correlated
-1.79%
RVPH - INM
30%
Poorly correlated
+2.54%
More